B. Gatalica et al., CLONING OF THE HUMAN TYPE-XVII COLLAGEN GENE (COL17A1), AND DETECTIONOF NOVEL MUTATIONS IN GENERALIZED ATROPHIC BENIGN EPIDERMOLYSIS-BULLOSA, American journal of human genetics, 60(2), 1997, pp. 352-365
Generalized atrophic benign epidermolysis bullosa (GABEB) is a nonleth
al variant of junctional epidermolysis bullosa (JEB). Previous finding
s have suggested that type XVII collagen is the candidate gene for mut
ations in this disease. We now have cloned the entire human type XVII
collagen gene (COL17A1) and have elucidated its intron-exon organizati
on. The gene comprises 56 distinct exons, which span similar to 52 kb
of the genome, on the long arm of chromosome 10. It encodes a polypept
ide, the alpha 1(XVII) chain, consisting of an intracellular globular
domain, a transmembrane segment, and an extracellular domain that cont
ains 15 separate collagenous subdomains, the largest consisting of 242
amino acids. We also have developed a strategy to identify mutations
in COL17A1 by use of PCR amplification of genomic DNA, using primers p
laced on the flanking introns. The PCR products are scanned for sequen
ce variants by heteroduplex analysis using conformation-sensitive gel
electrophoresis and then are subjected to direct automated sequencing.
We have identified several intragenic polymorphisms in COL17A1, as we
ll as mutations, in both alleles, in two Finnish families with GABEB.
The probands in both families showed negative immunofluorescence stain
ing with an anti-type XVII collagen antibody. In one family, the proba
nd was homozygous for a 5-bp deletion, 2944del5, which resulted in fra
meshift and a premature termination codon of translation. The proband
in the other family was a compound heterozygote, with one allele conta
ining the 2944del5 mutation and the other containing a nonsense mutati
on, Q1023X. These results expand the mutation database in different va
riants of JEB, and they attest to the functional importance of type XV
II collagen as a transmembrane component of the hemidesmosomes at the
dermal/epidermal junction.